61 results on '"C. Brochu"'
Search Results
2. Author Correction: Paleogenomics illuminates the evolutionary history of the extinct Holocene 'horned' crocodile of Madagascar, Voay robustus
- Author
-
E. Hekkala, J. Gatesy, A. Narechania, R. Meredith, M. Russello, M. L. Aardema, E. Jensen, S. Montanari, C. Brochu, M. Norell, and G. Amato
- Subjects
Biology (General) ,QH301-705.5 - Published
- 2021
- Full Text
- View/download PDF
3. The Miller Forensic Assessment of Symptoms Test (M-FAST) in Veterans
- Author
-
Robert D. Shura, Holly M. Miskey, Esteban Puente-López, Hadley C. Brochu, Anna T. Magnante, Victoria L. O'Connor, Sarah L. Martindale, and Jared A. Rowland
- Subjects
Neuropsychology and Physiological Psychology ,General Neuroscience - Published
- 2023
- Full Text
- View/download PDF
4. Poster session III * Friday 10 December 2010, 08:30-12:30
- Author
-
D. Guldbrand, O. Goetzsche, B. Eika, N. Watanabe, M. Taniguchi, T. Akagi, N. Koide, S. Sano, B. Orbovic, B. Obrenovic-Kircanski, S. Ristic, L. J. Soskic, F. Alhabshan, A. Jijeh, H. Abo Remsh, A. Alkhaldi, H. K. Najm, Z. Gasior, M. Skowerski, A. Kulach, L. Szymanski, M. Sosnowski, M. Wang, C. W. Siu, K. Lee, W. S. Yue, G. H. Yan, S. Lee, C. P. Lau, H. F. Tse, K. O'connor, M. Rosca, J. Magne, G. Romano, M. Moonen, L. A. Pierard, P. Lancellotti, M. Floria, L. De Roy, D. Blommaert, J. Jamart, F. Dormal, M. Lacrosse, C. Arsenescu Georgescu, V. Mizariene, S. Bucyte, A. Bertasiute, E. Pociute, D. Zaliaduonyte-Peksiene, K. Baronaite-Dudoniene, R. Sileikiene, J. Vaskelyte, R. Jurkevicius, M. Dencker, O. Thorsson, M. K. Karlsson, C. Linden, P. Wollmer, L. B. Andersen, O. Catalano, M. R. Perotti, E. Colombo, M. De Giorgi, M. Cattaneo, F. Cobelli, S. G. Priori, C. Ober, I. A. Iancu Adrian, P. A. Andreea Parv, C. H. Cadis Horatiu, O. M. Ober Mihai, M. Chmielecki, M. Fijalkowski, R. Galaska, W. Dubaniewicz, L. Lewicki, R. Targonski, D. Ciecwierz, W. Puchalski, A. Koprowski, A. Rynkiewicz, K. Hristova, A. La Gerche, T. Z. Katova, V. Kostova, Y. Simova, A. Kempny, G. P. Diller, S. Orwat, G. Kaleschke, G. Kerckhoff, R. Schmidt, R. M. Radke, H. Baumgartner, K. Smarz, B. Zaborska, T. Jaxa-Chamiec, P. Maciejewski, A. Budaj, A. Kiotsekoglou, S. C. Govind, V. Gadiyaram, J. C. Moggridge, M. Govindan, A. S. Gopal, S. S. Ramesh, L. A. Brodin, S. K. Saha, I. S. Ramzy, P. Lindqvist, Y. Y. Lam, A. M. Duncan, M. Y. Henein, I. S. Craciunescu, M. Serban, M. Iancu, C. Revnic, B. A. Popescu, D. Alexandru, D. Rogoz, V. Uscatescu, C. Ginghina, G. Careri, A. Di Monaco, R. Nerla, P. Tarzia, P. Lamendola, A. Sestito, G. A. Lanza, F. Crea, F. Giannini, B. Pinamonti, S. Santangelo, A. Perkan, G. Vitrella, S. Rakar, M. Merlo, E. Della Grazia, A. Salvi, G. Sinagra, P. Scislo, J. Kochanowski, R. Piatkowski, M. Roik, M. Postula, G. Opolski, J. Castillo, N. Herszkowicz, C. Ferreira, M. T. Lonnebakken, E. M. Staal, J. E. Nordrehaug, E. Gerdts, M. Przewlocka-Kosmala, A. Orda, B. Karolko, G. Bajraktari, U. Gustafsson, A. Holmgren, S. Frattini, P. Faggiano, V. Zilioli, E. Locantore, S. Longhi, F. Bellandi, G. Faden, M. Triggiani, L. Dei Cas, S. M. Seo, H. O. Jung, S. H. An, S. Y. Jung, C. S. Park, H. K. Jeon, H. J. Youn, W. B. Chung, J. H. Kim, J. S. Uhm, W. Mampuya, M. C. Brochu, D. H. Do, B. Essadiqi, P. Farand, S. Lepage, M. J. Daly, M. Monaghan, A. Hamilton, C. Lockhart, V. Kodoth, C. Maguire, A. Morton, G. Manoharan, M. S. Spence, W. Streb, K. Mitrega, J. Nowak, A. Duszanska, M. Szulik, M. Kalinowski, T. Kukulski, Z. Kalarus, F. E. Calvo Iglesias, I. Solla-Ruiz, I. Villanueva-Benito, E. Paredes-Galan, M. Bravo-Amaro, A. Iniguez-Romo, O. Yildirimturk, F. F. Helvacioglu, Y. Tayyareci, S. Yurdakul, I. C. Demiroglu, S. Aytekin, R. Enache, R. Piazza, D. Muraru, A. Roman-Pognuz, A. Calin, E. Leiballi, F. Antonini-Canterin, G. L. Nicolosi, C. Ridard, A. Bellouin, C. Thebault, M. Laurent, E. Donal, A. Sutandar, B. B. Siswanto, I. Irmalita, G. Harimurti, A. Saxena, S. Ramakrishnan, A. Roy, A. Krishnan, P. Misra, B. Bhargava, P. A. Poole-Wilson, B. B. Loegstrup, H. R. Andersen, S. H. Poulsen, K. E. Klaaborg, H. E. Egeblad, X. Gu, X. Y. Gu, Y. H. He, Z. A. Li, J. C. Han, J. Chen, N. Mansencal, E. Mitry, P. Rougier, O. Dubourg, H. Villarraga, K. Adjei-Twum, T. K. M. Cudjoe, A. Clavell, R. M. Schears, F. Cabrera Bueno, M. J. Molina Mora, J. Fernandez Pastor, A. Linde Estrella, J. L. Pena Hernandez, G. Isasti Aizpurua, F. Carrasco Chinchilla, A. Barrera Cordero, F. J. Alzueta Rodriguez, E. De Teresa Galvan, G. C. Gaetano Contegiacomo, F. P. Francesco Pollice, P. P. Paolo Pollice, M. C. Kontos, D. H. Shin, S. Y. Yoo, C. K. Lee, J. K. Jang, S. I. Jung, S. I. Song, S. I. Seo, S. S. Cheong, J. Peteiro, A. Perez-Perez, A. Bouzas-Mosquera, M. Pineiro, P. Pazos, R. Campo, A. Castro-Beiras, N. Gaibazzi, F. Rigo, D. Sartorio, C. Reverberi, S. Sitia, L. Tomasoni, L. Gianturco, L. Ghio, D. Stella, P. Greco, V. De Gennaro Colonna, M. Turiel, S. Cicala, V. Magagnin, E. Caiani, S. Kyrzopoulos, D. Tsiapras, G. Domproglou, E. Avramidou, V. Voudris, K. Wierzbowska-Drabik, P. Lipiec, L. Chrzanowski, N. Roszczyk, K. Kupczynska, J. D. Kasprzak, V. Sachpekidis, A. Bhan, S. Gianstefani, J. Reiken, M. Paul, P. Pearson, D. Harries, M. J. Monaghan, K. Dale, A. Stoylen, V. Kodali, R. Toole, P. Raju, R. A. Mcintosh, J. Silberbauer, O. Baumann, N. R. Patel, N. Sulke, U. Trivedi, J. Hyde, G. Venn, G. Lloyd, P. Wejner-Mik, K. Wierzbowska, J. A. Lowenstein, C. Caniggia, A. Garcia, M. Amor, N. Casso, D. Lowenstein Haber, C. Porley, G. Zambrana, V. Daru, M. Deljanin Ilic, S. Ilic, D. Kalimanovska Ostric, V. Stoickov, M. Zdravkovic, I. Paraskevaidis, I. Ikonomidis, J. Parissis, C. Papadopoulos, V. Stasinos, V. Bistola, M. Anastasiou-Nana, M. Gudin Uriel, J. R. Balaguer Malfagon, J. L. Perez Bosca, F. Ridocci Soriano, N. Martinez Alzamora, R. Paya Serrano, Q. Ciampi, L. Pratali, M. Della Porta, B. Petruzziello, B. Villari, E. Picano, R. Sicari, A. Rosner, D. Avenarius, S. Malm, A. Iqbal, A. Baltabaeva, G. R. Sutherland, B. Bijnens, T. Myrmel, M. Andersen, F. Gustafsson, N. H. Secher, P. Brassard, A. S. Jensen, C. Hassager, P. L. Madsen, J. E. Moller, M. Coutu, D. Greentree, D. Normandin, H. Brun, A. Dipchand, L. Koopman, C. T. Fackoury, S. Truong, C. Manlhiot, L. Mertens, M. Baroni, M. Mariani, H. K. Chabane, S. Berti, A. Ripoli, S. Storti, M. Glauber, P. A. Scopelliti, G. B. Antongiovanni, D. Personeni, A. Saino, M. Tespili, P. Jung, M. Mueller, F. Jander, H. Y. Sohn, J. Rieber, P. Schneider, V. Klauss, E. Agricola, M. Slavich, S. Stella, M. Ancona, M. Oppizzi, L. Bertoglio, G. Melissano, A. Margonato, R. Chiesa, L. Cejudo Diaz Del Campo, D. Mesa Rubio, M. Ruiz Ortiz, M. Delgado Ortega, E. Villanueva Fernandez, J. Lopez Aguilera, F. Toledano Delgado, M. Pan Alvarez-Ossorio, J. Suarez De Lezo Cruz Conde, M. Lafuente, T. Butz, A. Meissner, C. N. Lang, M. W. Prull, G. Plehn, H. J. Trappe, S. V. Nair, L. Lee, I. Mcleod, G. Whyte, J. Shrimpton, D. Hildick Smith, P. R. James, J. Slikkerveer, Y. E. A. Appelman, G. Veen, T. R. Porter, O. Kamp, P. Colonna, F. J. Ten Cate, D. Bokor, A. Daponte, M. Cocciolo, M. Bona, S. Sacchi, H. Becher, S. C. Chai, P. J. Tan, Y. S. Goh, S. H. Ong, J. Chow, L. L. Lee, P. P. Goh, K. L. Tong, R. Kakihara, C. Naruse, H. Hironaka, T. Tsuzuku, K. Ozawa, A. Tomaszuk-Kazberuk, B. Sobkowicz, J. Malyszko, J. S. Malyszko, R. Sawicki, T. Hirnle, S. Dobrzycki, M. Mysliwiec, W. J. Musial, W. Mathias, I. Kowatsch, A. L. R. Saroute, A. F. F. Osorio, J. C. N. Sbano, J. A. F. Ramires, J. M. Tsutsui, K. Sakata, H. Ito, K. Ishii, T. Sakuma, K. Iwakura, H. Yoshino, J. Yoshikawa, K. Shahgaldi, A. Lopez, B. Fernstrom, A. Sahlen, R. Winter, S. Kovalova, J. Necas, B. H. Amundsen, R. Jasaityte, G. Kiss, D. Barbosa, J. D'hooge, H. Torp, C. A. Szmigielski, J. D. Newton, K. Rajpoot, J. A. Noble, R. Kerber, L. P. Koopman, C. Slorach, N. Chahal, W. Hui, T. Sarkola, T. J. Bradley, E. T. Jaeggi, B. W. Mccrindle, A. Staron, M. Jasinski, S. Wos, P. Sengupta, D. Hayat, M. Kloeckner, J. Nahum, C. Dussault, J. L. Dubois Rande, P. Gueret, P. Lim, G. J. King, A. Brown, E. Ho, I. Amuntaser, K. Bennet, N. Mc Elhome, R. T. Murphy, R. M. Cooper, J. D. Somauroo, R. E. Shave, K. L. Williams, J. Forster, C. George, T. Bett, K. P. George, A. D'andrea, L. Riegler, R. Cocchia, E. Golia, R. Gravino, G. Salerno, R. Citro, P. I. O. Caso, E. Bossone, R. Calabro', F. Crispi, F. Figueras, J. Bartrons, E. Eixarch, F. Le Noble, A. Ahmed, E. Gratacos, Q. Shang, W. K. Yip, L. S. Tam, Q. Zhang, C. M. Li, T. Wang, C. Y. Ma, K. M. Li, C. M. Yu, T. Dahlslett, I. Helland, T. Edvardsen, H. Skulstad, L. S. Magda, M. Florescu, A. Ciobanu, R. Dulgheru, R. Mincu, D. Vinereanu, M. Luckie, S. Chacko, S. Nair, M. Mamas, R. S. Khattar, M. El-Omar, A. Kuch-Wocial, P. Pruszczyk, M. Szulc, G. Styczynski, M. Sinski, A. Kaczynska, Z. Vela, E. Haliti, V. Hyseni, R. Olloni, N. Rexhepaj, S. Elezi, J. J. Onaindia, O. Quintana, A. Cacicedo, S. Velasco, J. J. Alarcon, M. Morillas, J. R. Rumoroso, J. Zumalde, I. Lekuona, E. Laraudogoitia Zaldumbide, A. Poniku, A. Ahmeti, R. F. Duncan, J. M. Mccomb, J. Pemberton, S. W. Lord, D. Leong, C. Plummer, G. Macgowan, N. Grubb, M. Leung, A. Kenny, C. Prinz, J. U. Voigt, A. Zaidi, M. Heatley, S. Z. Abildstrom, A. Hvelplund, J. Berning, S. Govind, L. Brodin, A. Gopal, B. Castaldi, G. Di Salvo, G. Santoro, G. Gaio, M. T. Palladino, C. Iacono, G. Pacileo, M. G. Russo, R. Calabro, Y. S. Wang, L. L. Dong, X. H. Shu, C. Z. Pan, D. X. Zhou, T. Sen, O. Tufekcioglu, M. Ozdemir, A. Tuncez, B. Uygur, Z. Golbasi, H. Kisacik, L. Delfino, F. D. De Leo, L. C. Chiappa, B. Abdel Ghani, R. Schiavina, P. Salvade, A. Morganti, F. Bedogni, P. Mahia, L. Gutierrez, V. Pineda, B. Garcia, I. Otaegui, J. F. Rodriguez, M. T. Gonzalez, M. Descalzo, A. Evangelista, D. Garcia-Dorado, H. A. C. M. Bruin De- Bon, R. B. A. Van Den Brink, S. Surie, P. Bresser, J. Vleugels, H. M. Eckmann, D. A. Samson, B. J. Bouma, C. Dedobbeleer, M. Antoine, M. Remmelink, P. Unger, B. Roosens, I. Hmila, S. Hernot, S. Droogmans, G. Van Camp, T. Lahoutte, S. Muyldermans, B. Cosyns, G. Feltes, V. Serra, O. Azevedo, J. Barbado, J. Herrera, A. Rivera, J. Paniagua, V. Valverde, J. Torras, G. Arriba, T. Christodoulides, M. Ioannides, K. Simamonian, K. Yiangou, M. Myrianthefs, E. Nicolaides, M. Pandolfo, S. A. Kleijn, M. F. A. A. Aly, C. B. Terwee, A. C. Van Rossum, V. Delgado, M. Shanks, H. M. Siebelink, A. Sieders, H. Lamb, N. Ajmone Marsan, J. Westenberg, A. De Roos, J. D. Schuijf, J. J. Bax, A. M. Anwar, Y. Nosir, H. Chamsi-Pasha, H. D. Tschernich, J. Seeburger, M. Borger, C. Mukherjee, F. W. Mohr, J. Ender, K. Obase, H. Okura, R. Yamada, Y. Miyamoto, K. Saito, K. Imai, A. Hayashida, and K. Yoshida
- Subjects
medicine.medical_specialty ,business.industry ,Physical therapy ,Medicine ,Radiology, Nuclear Medicine and imaging ,General Medicine ,Session (computer science) ,Cardiology and Cardiovascular Medicine ,business - Published
- 2010
- Full Text
- View/download PDF
5. Éléments contextuels associés à l'émission de comportements d'agitation verbale présentés par des personnes âgées institutionnalisées atteintes de démence
- Author
-
J. Aubert, P. Landreville, J. Vézina, C. Laplante, C. Brochu, G. Primeau, and S. Imbeault
- Subjects
Applied Psychology - Abstract
Resume La presente recherche etudie dans quel contexte sont emis des comportements d'agitation verbale (AV). L'etude a ete realisee aupres de 15 participants atteints de demence, residant en institution et presentant des comportements agites. Les participants ont fait l'objet d'une observation assistee par un ordinateur de main. La frequence et la duree des episodes d'agitation ont ete calculees. L'heure, le lieu, l'activite pratiquee, la presence d'autres personnes et l'utilisation de contention ont ete notes. Au total, 180 heures d'observation ont ete realisees, chaque participant etant observe pendant 12 heures, soit de 8 h00 a 20 h00. Les resultats montrent que les participants sont verbalement agites 10 % du temps. L'AV est emise lorsque les participants sont dans leur chambre (94 %), non engages dans une activite particuliere (81 %), seuls (80 %) et contentionnes (78 %). L'AV emerge surtout apres 14 h00 (73 %). Certaines caracteristiques contextuelles sont associees a de plus grandes concentrations d'AV que d'autres.
- Published
- 2007
- Full Text
- View/download PDF
6. Novel Benzimidazole Derivatives as Selective CB2 Inverse Agonists
- Author
-
Stephane St-Onge, Hua Yang, D. Salois, M.-C. Brochu, E. Martin, Page Daniel, and William Brown
- Subjects
Benzimidazole ,chemistry.chemical_compound ,chemistry ,Drug Discovery ,Pharmaceutical Science ,Molecular Medicine ,Inverse agonist ,Combinatorial chemistry - Published
- 2006
- Full Text
- View/download PDF
7. Mathematical Modeling of the Magnesium Refining Furnace
- Author
-
Y. M. Rybukhin, R. Hachette, C. Brochu, G. Simard, D. Argo, R.T. Bui, R. Sheng, and M. Smith
- Subjects
Materials science ,chemistry ,Waste management ,Magnesium ,Metallurgy ,chemistry.chemical_element ,Refining (metallurgy) ,Electric arc furnace - Published
- 2013
- Full Text
- View/download PDF
8. A new basal eusuchian crocodile from the Late Cretaceous of Lo Hueco (Cuenca, Spain)
- Author
-
I Narváez, F Ortega, C Brochu, and Escaso
- Published
- 2013
- Full Text
- View/download PDF
9. Réponse de la flore bactérienne de l'estuaire du Saint-Laurent à un éventuel déversement de pétrole
- Author
-
Daniel Delille, Robert Siron, C. Brochu, and Émilien Pelletier
- Subjects
Environmental science ,Water Science and Technology - Abstract
Résumé Un groupe de cinq mésocosmes de 3,5 m3 chacun, permettant de travailler en eaux froides, a été utilisé pour étudier l’évolution de la flore bactérienne de l’estuaire du Saint-Laurent sous différentes conditions de contamination (pétrole dispersé chimiquement, non traité ou relargué à partir d’un substrat) et à différentes saisons (températures de l’eau de mer variant de −1,8 à 16°C). Des concentrations en pétrole de
- Published
- 1993
- Full Text
- View/download PDF
10. Suivi d’une contamination pétrolière accidentelle dans l’estuaire moyen du Saint-Laurent: Le cas de l’Ile-aux-Grues
- Author
-
R. Siron, Émilien Pelletier, and C. Brochu
- Subjects
Environmental science ,Water Science and Technology - Abstract
Le sédiment superficiel (0-3cm), l’eau interstitielle, les particules en suspension et l’eau de surface autour de l’Ile-aux-Grues (Québec, Canada) ont été échantillonnés en mai 1988 (11 jours après le déversement du pétrolier Czantoria) et en juin 1990. Les concentrations en hydrocarbures totaux mesurées par spectrofluorescence révèlent l’enrichissement des particules en suspension relativement à la fraction dissoute et au sédiment. Les analyses en chromatographie en phase gazeuse montrent que la contamination pétrolière du sédiment a été très ponctuelle. En mai 88, seulement deux stations montraient les indices d’une forte contamination pétrolière du sédiment, qui n’était plus décelée significativement deux ans après. A l’une de ces stations, la biodégradation des hydrocarbures semblait très avancée dans le sédiment, alors que l’eau interstitielle était enrichie en dérivés naphtaléniques. Des résidus de type émulsions “d’eau-dans-1’huile” non altérés étaient retrouvés adsorbés sur des rochers aux deux extrémités de l’ile, 11 jours après l’accident. Dans le sédiment prélevé en mai 88, l’origine fossile des hydrocarbures se superpose à un “bruit de fond” dans lequel on peut distinguer une importante contribution biogénique (n-alcanes à chaînes impaires, rétène, pérylène). Durant les deux séries d’échantillonnage, tous les hydrocarbures aromatiques polycycliques (HAP) dérivés de combustion ont été retrouvés à des niveaux relativement faibles dans le sédiment, confirmant la légère contamination pyrogénique à laquelle le site étudié est soumis.
- Published
- 1991
- Full Text
- View/download PDF
11. Preliminary evidence of safety following administration of L-DOPA and buspirone in an incomplete monoplegic patient
- Author
-
C Brochu and Pierre A. Guertin
- Subjects
Adult ,Male ,Levodopa ,Central Nervous System Venous Angioma ,Movement ,Treatment outcome ,Cerebral palsy ,Buspirone ,Antiparkinson Agents ,Postoperative Complications ,Anti-Anxiety Agents ,medicine ,Humans ,Leg ,Dose-Response Relationship, Drug ,business.industry ,Cerebral Palsy ,General Medicine ,medicine.disease ,nervous system diseases ,Treatment Outcome ,Neurology ,Regional Blood Flow ,Anesthesia ,Drug Therapy, Combination ,Neurology (clinical) ,business ,Administration (government) ,medicine.drug - Abstract
Case report.To report a case where a monoplegic patient received L-DOPA and/or buspirone. These compounds, normally used in the treatment of Parkinson's disease and anxiety respectively, were recently shown to induce spinal locomotor network activity and reflex stepping-like movements in animal models of spinal cord injury (SCI). However, the safety of these drugs as potential treatments for Central Pattern Generator (CPG) activation in paralyzed individuals remain unclear.St-Jean-Chrysostome, Quebec, Canada.The acute effects induced by these compounds were qualitatively assessed by the patient, a 38-year-old man who underwent surgery 17 years ago to remove an intracavernous angioma located at the mid-thoracic level (T5-T6) of the spinal cord.Self-administration every 2 days of L-DOPA (200, 400 and 600 mg, p.o.) and buspirone (5, 10 and 15 mg, p.o.) either separately or combined led to no atypical side effects (that is, occasional sleepiness, nervousness, insomnia or mild headaches). No movement was induced ipsilaterally although some sensations referred to by the patient as an increased blood flow in the lower back and upper leg regions were reported shortly after administration of the combined treatment.The results show no significant side effects following acute administration of L-DOPA and/or buspirone. This constitutes the first report providing preliminary evidence of safety following administration of these drugs in incompletely paralyzed individuals. The sensations of increased blood flow ipsilaterally with the combined treatment may also suggest that the dose regimen was not optimal or sub-threshold for inducing detectable CPG-mediated leg movements.
- Published
- 2008
12. Lack of suppressive effects of mixtures containing low levels of methylmercury (MeHg), polychlorinated dibenzo-p-dioxins (PCDDS), polychlorinated dibenzofurans (PCDFS), and aroclor biphenyls (PCBS) on mixed lymphocyte reaction, phagocytic, and natural killer cell activities of rat leukocytes in vitro
- Author
-
Francine Denizeau, C. Brochu, Edouard F. Potworowski, Felix Olima Omara, Denis Flipo, Pauline Brousseau, and Michel Fournier
- Subjects
Male ,Aroclors ,Polychlorinated Dibenzodioxins ,Phagocyte ,Cell Survival ,Health, Toxicology and Mutagenesis ,Lymphocyte ,T-Lymphocytes ,Toxicology ,Natural killer cell ,chemistry.chemical_compound ,In vivo ,medicine ,Splenocyte ,Animals ,Soil Pollutants ,Methylmercury ,Benzofurans ,Phagocytes ,Dibenzofurans, Polychlorinated ,Methylmercury Compounds ,Molecular biology ,Polychlorinated Biphenyls ,Rats, Inbred F344 ,Rats ,Killer Cells, Natural ,medicine.anatomical_structure ,chemistry ,Environmental chemistry ,Toxicity ,Lymphocyte Culture Test, Mixed ,Polychlorinated dibenzofurans ,Spleen - Abstract
Rat splenocyte mixed leukocyte reaction (MLR), splenic natural killer (NK) cell activity, and phagocytic activities of splenic, peritoneal, and peripheral blood leukocytes (PBLs) were evaluated in vitro to determine the immunotoxicity of mixtures containing low levels of methylmercury (MeHg), polychlorinated dibenzo-p-dioxins (PCDDs), polychlorinated dibenzofurans (PCDFs), and Aroclor polychlorinated biphenyls (PCBs). The mixtures were based on the concentrations of the chemicals in fish flesh. Leukocytes from male Fischer rats were exposed to MeHg (0.1-2 microg/ml), PCDD/PCDF mixtures (1-15 pg/ml) of three PCDDs (2,3,7,8-tetrachlorodibenzo-p-dioxin, 1,2,3,7,8-pentachlorodibenzo-p-dioxin, and 1,2,3,4,7,8-hexachlorodibenzo-p-dioxin) and two PCDFs (2,3,7,8-tetrachlorodibenzofuran and 1,2,3,7,8-pentachlorodibenzofuran), three Aroclor PCB (Aroclor 1242, 1254, and 1260) mixtures (0.01-0.5 microg/ml), or combinations of MeHg/PCB/PCDD/PCDF mixtures for 24 or 72 h before immunological assays. Phagocytosis and NK cell cytotoxicity were evaluated with a flow cytometer, and MLR of Fischer rat responder splenocytes cultured with mitomycin C-treated Long-Evans splenocytes by [3H]thymidine uptake. Exposure to MeHg (2 microg/ml) alone or with PCB/ PCDD/PCDF resulted in significant cytolethality in rat splenocytes, peritoneal leukocytes, and PBLs at 24 h exposure. Treatment with Aroclor PCB mixtures, PCDD/PCDF mixtures, 0.1 microg MeHg/ml (noncytolethal), or PCB/PCDD/PCDF mixtures with 0.1 microg MeHg/ml caused no suppression of splenocyte MLR response, splenic NK cell-mediated lysis of Yac-l cells, or phagocytosis of fluorescent beads by splenic, peritoneal, and peripheral blood phagocytic cells. The results indicate that in vitro exposure of rat leukocytes to low levels of MeHg, Aroclor PCB mixtures, PCDD/PCDF mixtures, or MeHg/PCB/PCDD/PCDF mixtures had no suppressive effects on the immune functions assayed, and thus produced no additive immunotoxicity. However, in order to predict the potential risk of these chemical mixtures to the human immune system, in vivo animal studies with blood (tissue) levels compatible with the levels of MeHg, PCBs, and PCDDs/PCDFs in exposed human populations should be evaluated.
- Published
- 1998
13. Environmental factors influencing the biodegradation of petroleum hydrocarbons in cold seawater
- Author
-
R. Siron, Émilien Pelletier, and C. Brochu
- Subjects
chemistry.chemical_classification ,Detritus ,Ecology ,Health, Toxicology and Mutagenesis ,General Medicine ,Contamination ,Biodegradation ,Toxicology ,Pollution ,Mesocosm ,chemistry.chemical_compound ,Hydrocarbon ,chemistry ,Environmental chemistry ,Petroleum ,Seawater ,Water pollution - Abstract
A group of five mesocosms (3.5 m3 each) located at Pointe-au-Pere (St. Lawrence Estuary), Canada, was used to study the biodegradation of crude oil dispersed in cold and icy seawater (−1.8 to 5.5°C) under various environmental conditions. Experiments took place during autumn, winter, and spring and lasted from 2 weeks to 2 months. The bacterial response to the oil was assessed by recording the growth of total bacteria, viable heterotrophic bacteria, and oil-degrading bacteria. Some hydrocarbon ratios were calculated from gas chromatography in aliphatic and aromatic oil fractions and were used as biodegradation indices. A “Combined Index of Biodegradation” is proposed for assessing the overall biodegradation advancement. The winter period appeared critical for an oil spill in arctic/subarctic environments because of the reduced biodegradation under icy conditions. Crude oil adsorbed onto a substrate was found more degraded on its immersed part than on the emerged section exposed to winter conditions. Under more favorable environmental conditions (temperatures >0°C, effective chemical dispersion, oil release, spring microalgal bloom), the bacterial degradation would significantly alter the dissolved/dispersed oil within a few days. Under such conditions, half-life times of dissolved petroleum PAH ranged from 1.5–1.7 days (naphthalene) to 2.4–7.5 days (dimethylphenanthrenes), depending on the contamination level. In microenvironments where oil residues accumulated with biological detritus (surface microlayer, settling matter), the oil biodegradation was naturally enhanced. In contrast, water-in-oil emulsions recovered at the surface of mesocosms were unaltered after one month exposure in autumn.
- Published
- 1995
- Full Text
- View/download PDF
14. A294 INTENSIVE CARE UNIT OUTCOME OF PATIENTS RECEIVING CHRONIC HEMODIALYSIS
- Author
-
C Brochu, H L Corwin, and A Gettinger
- Subjects
medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Intensive care unit ,Outcome (game theory) ,law.invention ,Anesthesiology and Pain Medicine ,law ,Critical care nursing ,medicine ,Chronic hemodialysis ,Hemodialysis ,Intensive care medicine ,business - Published
- 1990
- Full Text
- View/download PDF
15. A238 CLINICAL ACCURACY OF A NEW MODULAR MIXED-VENOUS SATURATION OXIMETER
- Author
-
I Mroz, P Wager, A Gettinger, and C Brochu
- Subjects
Anesthesiology and Pain Medicine ,business.industry ,Medicine ,Modular design ,Saturation (chemistry) ,business ,Biomedical engineering - Published
- 1990
- Full Text
- View/download PDF
16. FP 5 Immunotoxicity of complex mixtures in rat and human
- Author
-
F. Denizeau, P. Brousseau, Felix Olima Omara, C. Brochu, D. Flipo, Edouard F. Potworowski, and Michel Fournier
- Subjects
Immunology ,Pharmacology ,Biology ,Developmental Biology - Published
- 1997
- Full Text
- View/download PDF
17. FP 3 Validation of mouse fetal thymic organ culture as bioassay to monitor immunotoxic potential of xenobiotics
- Author
-
C. Beauchemin, Edouard F. Potworowski, C. Brochu, F. Denizeau, Michel Fournier, and P. Brousseau
- Subjects
chemistry.chemical_compound ,chemistry ,Immunology ,Bioassay ,Pharmacology ,Biology ,Xenobiotic ,Developmental Biology ,Fetal Thymic Organ Culture - Published
- 1997
- Full Text
- View/download PDF
18. Quantitative Budget of Chemically Dispersed Crude Oil in ICY Seawater: An Experimental Approach
- Author
-
R. Siron, C. Brochu, and E. Pelletier
- Subjects
Petroleum engineering ,Seawater ,Crude oil ,Geology - Published
- 1991
- Full Text
- View/download PDF
19. The Effects of Chemical Dispersion on Long-Term Weathering of Crude Oil in Cold Seawater
- Author
-
J. Desnoyers, Émilien Pelletier, C. Brochu, and J. H. Vandermeulen
- Subjects
Hydrology ,chemistry.chemical_compound ,Water column ,chemistry ,Oil droplet ,Environmental chemistry ,Petroleum ,Seawater ,Weathering ,Biodegradation ,Crude oil ,Dispersion (chemistry) ,Geology - Abstract
The effects of chemical dispersion on crude oil weathering in cold seawater have been studied in a mesoscale simulator (1,675 L) under ambient air conditions. Oil droplets dispersed in the contained water column were rapidly biodegraded during the fall experiment whereas the bacterial activity was reduced by at least one order of magnetude in experiments conducted below an ice cover. Undispersed oil formed a water in oil emulsion (chocolate mousse) very resistant to weathering processes. During winters mousses were trapped in ice and recovered almost unchanged 3 to 4 months later.
- Published
- 1987
- Full Text
- View/download PDF
20. NEW PROTECTED EXPERIMENTAL TANKS FOR ENVIRONMENTAL STUDIES UNDER SEVERE WEATHER CONDITIONS
- Author
-
S. Roy, Émilien Pelletier, C. Brochu, and P. Mayzaud
- Subjects
Environmental studies ,Severe weather ,Environmental science ,Environmental planning - Published
- 1989
- Full Text
- View/download PDF
21. LONG-TERM OIL WEATHERING UNDER SEA ICE IN EXPERIMENTAL MESOSCALE SIMULATOR
- Author
-
C. Brochu, J. H. Vandermeulen, and Émilien Pelletier
- Subjects
geography ,geography.geographical_feature_category ,Oceanography ,Mesoscale meteorology ,Sea ice ,Weathering ,Geology ,Term (time) - Published
- 1987
- Full Text
- View/download PDF
22. Doppler Spreading of Reverberation in Shallow Water
- Author
-
J. M. Ross and C. Brochu
- Subjects
Reverberation ,Acoustics and Ultrasonics ,Scattering ,Acoustics ,Mineralogy ,Surface conditions ,Waves and shallow water ,symbols.namesake ,Transducer ,Arts and Humanities (miscellaneous) ,Thermal ,symbols ,Doppler effect ,Geology - Abstract
Reverberation data have been gathered with a narrow‐beam transducer, which transmitted a 1.4 sec CW pulse at 9.5 khz. The transducer was towed through the waters of the Scotian Shelf and Gulf of St. Lawrence at various depths. Conditions exist in these relatively shallow water areas where surface, volume, and bottom are all, at different times, the dominant backscattering mechanism. In winter, because of the typically strong positive thermal gradients, surface reverberation dominates. In summer, two common situations exist: (1) a strong negative gradient, where bottom is the dominant backscatterer, and (2) a pronounced sound channel where volume may be the dominant backscatterer if leakage is small. If sufficient leakage occurs, contributions from bottom and volume reverberation can both be significant. When surface reverberation dominates, spectral bandwidths are a function of the sea surface conditions. When bottom reverberation is dominant, the spectral spreading is greater than that associated with the system resolution, probably due to variations in shear currents. The spreading associated with volume reverberation lies between that of bottom and surface backscattering, but the scattering strength is significantly lower.
- Published
- 1973
- Full Text
- View/download PDF
23. At Arm's Length: ICU Quick Reference Cards.
- Author
-
G., Corliss and C., Brochu
- Subjects
- *
INTENSIVE care nursing - Abstract
An abstract of the article "At Arm's Length: ICU Quick Reference Cards," by G. Corliss and C. Brochu is presented.
- Published
- 2008
24. Assessing the relative validity of a web-based self-administered 24-hour dietary recall in a Canadian adolescent's population.
- Author
-
Drapeau V, Laramée C, Lafreniere J, Trottier C, Brochu C, Robitaille J, Lamarche B, and Lemieux S
- Subjects
- Humans, Adolescent, Female, Male, Quebec, Child, Reproducibility of Results, Diet methods, Diet statistics & numerical data, Diet Surveys methods, Nutrition Assessment, Feeding Behavior, Diet Records, Mental Recall, Internet, Energy Intake
- Abstract
Background: Healthy eating habits at a young age are crucial to support growth and development and good general health. In this context, monitoring youth dietary intakes adequately with valid tools is important to develop efficient interventions and identify groups that are more at risk of inadequate intakes. This study aimed to assess the relative validity of the self-administered web-based 24-h dietary recall (R24W) for evaluating energy and nutrient intakes among active adolescents., Methods: Participants were invited to complete one interviewer-administered 24-h dietary dietary recall and the R24W on up to three occasions within one month. A total of 272 French-speaking active adolescents aged 12 to 17 years from the province of Québec were invited to complete three R24W and one interview-administered 24-h recall. Student's t-test and correlations were conducted on sex-adjusted data. Percent differences, cross-classification (percentage of agreement), weighted Kappa and Bland-Altman plots were calculated., Results: Mean (SD) energy intake from the R24W was 8.8% higher than from the interview-administered 24-h dietary recall (2558 kcal ± 1128 vs. 2444 kcal ± 998, p < 0.05). Significant differences in mean nutrient intake between the R24W and the interview-administered 24-h dietary recall ranged from 6.5% for % E from fat (p < 0.05) to 25.2% for saturated fat (p < 0.001), i.e., higher values with R24W. Sex-adjusted correlations were significant for all nutrients except for % E from proteins and thiamin (range: 0.24 to 0.52, p < 0.01). Cross-classification demonstrated that 36.6% of the participants were classified in the same fourth with both methods, 39.6% in the adjacent fourth, and 5.7% misclassified. Bland-Atman plots revealed proportional bias between the two methods for 7/25 nutrients. Completing at least two recalls with the R24W increased the precision of intake estimates., Conclusion: These data suggest that the R24W presents an acceptable relative validity compared to a standard interview-administered 24-h recall for estimating energy and most nutrients in a cohort of French-speaking adolescents from the province of Québec., (© 2024. Crown.)
- Published
- 2024
- Full Text
- View/download PDF
25. SMARCAL1 ubiquitylation controls its association with RPA-coated ssDNA and promotes replication fork stability.
- Author
-
Yates M, Marois I, St-Hilaire E, Ronato DA, Djerir B, Brochu C, Morin T, Hammond-Martel I, Gezzar-Dandashi S, Casimir L, Drobetsky E, Cappadocia L, Masson JY, Wurtele H, and Maréchal A
- Subjects
- Humans, Replication Protein A genetics, Replication Protein A metabolism, Protein Binding, Ubiquitination, DNA Damage, Genomic Instability, DNA Helicases genetics, DNA Helicases metabolism, Ubiquitin-Protein Ligases genetics, Ubiquitin-Protein Ligases metabolism, DNA, Single-Stranded genetics, DNA Replication genetics
- Abstract
Impediments in replication fork progression cause genomic instability, mutagenesis, and severe pathologies. At stalled forks, RPA-coated single-stranded DNA (ssDNA) activates the ATR kinase and directs fork remodeling, 2 key early events of the replication stress response. RFWD3, a recently described Fanconi anemia (FA) ubiquitin ligase, associates with RPA and promotes its ubiquitylation, facilitating late steps of homologous recombination (HR). Intriguingly, RFWD3 also regulates fork progression, restart and stability via poorly understood mechanisms. Here, we used proteomics to identify putative RFWD3 substrates during replication stress in human cells. We show that RFWD3 interacts with and ubiquitylates the SMARCAL1 DNA translocase directly in vitro and following DNA damage in vivo. SMARCAL1 ubiquitylation does not trigger its subsequent proteasomal degradation but instead disengages it from RPA thereby regulating its function at replication forks. Proper regulation of SMARCAL1 by RFWD3 at stalled forks protects them from excessive MUS81-mediated cleavage in response to UV irradiation, thereby limiting DNA replication stress. Collectively, our results identify RFWD3-mediated SMARCAL1 ubiquitylation as a novel mechanism that modulates fork remodeling to avoid genome instability triggered by aberrant fork processing., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Yates et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
26. Winner for Life: A three-year study of student-athletes' life skills development in a training programme for coaches and teachers.
- Author
-
Carrière R, Trottier C, Drapeau V, Frenette É, Goulet C, Brochu C, Camiré M, and Lemyre PN
- Subjects
- Humans, Adolescent, Athletes, Students, Schools, Pandemics, Educational Personnel
- Abstract
Growing numbers of researchers have investigated how training programmes influence coaches' and teachers' ability to promote life skills development, and concurrently, athlete-related outcomes. This study aimed to examine high school student-athletes' development of life skills through a three-year programme called Winner for Life (Gagnant pour la vie). Delivered online to high school coaches and teachers, the programme targeted five life skills: (a) Goal Setting and Concentration (Year 1), (b) Healthy Eating Habits and Safety Behaviours (Year 2), and Physical and Mental Recovery (Year 3). In all, 148 student-athletes participated in the programme and completed questionnaires at five time points to assess life skills development. A general linear repeated measures model was used to assess changes over time. Missing data were handled using multiple imputations. Student-athletes reported higher scores on Goal Setting subscale at time 2 (vs. time 1) and time 3 (vs. time 2) and on Social Recovery subscale at time 2 (vs. time 1). They also reported lower scores on Sleep Quality subscale at time 3 (vs. time 2) and time 5 (vs. time 4). Additionally, a significant interaction was observed between student-athletes' age (mean = 13.5 years) at study start, and improvements on certain life skills subscales over time. Overall, the fact that student-athletes did not improve on all life skills could be explained by the COVID-19 pandemic lockdowns, which limited the programme's influence from time 3. Results should be considered in light of limitations regarding gender distribution and ceiling effects on student-athletes' scores. Recommendations to improve future life skills programmes are discussed, such as involving parents in delivery and encouraging life skills teaching over time., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
27. Online Learning Challenges and Strategies: Visual Fatigue and Split Visual Attention.
- Author
-
Luft P and Brochu C
- Subjects
- Humans, Learning, Multimedia, Education, Distance, Asthenopia, Hearing Loss
- Abstract
Online learning environments are challenging for deaf and hard of hearing (DHH) individuals. A major concern is split attention, which occurs when one simultaneously attends to multiple stimuli, a situation that characterizes most multimedia presentations and instruction that combines sound, text, images, graphs or charts, and video. Needing to take notes adds another stimulus. DHH learners face this issue when auditory content is accommodated visually, in combination with visually presented content. No one can view multiple visual signals simultaneously. Learners must choose to view one signal and miss others; view signals sequentially, which requires additional time and hinders class participation; or switch between visual signals, losing elements of each. This process increases auditory and visual fatigue and cognitive load, ultimately compromising learning. Several ways are suggested to achieve more equitable access to instructional content for learners challenged by the problem of split attention.
- Published
- 2023
- Full Text
- View/download PDF
28. Author Correction: Paleogenomics illuminates the evolutionary history of the extinct Holocene "horned" crocodile of Madagascar, Voay robustus.
- Author
-
Hekkala E, Gatesy J, Narechania A, Meredith R, Russello M, Aardema ML, Jensen E, Montanari S, Brochu C, Norell M, and Amato G
- Published
- 2021
- Full Text
- View/download PDF
29. Paleogenomics illuminates the evolutionary history of the extinct Holocene "horned" crocodile of Madagascar, Voay robustus.
- Author
-
Hekkala E, Gatesy J, Narechania A, Meredith R, Russello M, Aardema ML, Jensen E, Montanari S, Brochu C, Norell M, and Amato G
- Subjects
- Animals, Madagascar, Paleontology, Phylogeny, Alligators and Crocodiles genetics, Biological Evolution, DNA, Ancient analysis, Extinction, Biological, Fossils, Genomics methods
- Abstract
Ancient DNA is transforming our ability to reconstruct historical patterns and mechanisms shaping modern diversity and distributions. In particular, molecular data from extinct Holocene island faunas have revealed surprising biogeographic scenarios. Here, we recovered partial mitochondrial (mt) genomes for 1300-1400 year old specimens (n = 2) of the extinct "horned" crocodile, Voay robustus, collected from Holocene deposits in southwestern Madagascar. Phylogenetic analyses of partial mt genomes and tip-dated timetrees based on molecular, fossil, and stratigraphic data favor a sister group relationship between Voay and Crocodylus (true crocodiles). These well supported trees conflict with recent morphological systematic work that has consistently placed Voay within Osteolaeminae (dwarf crocodiles and kin) and provide evidence for likely homoplasy in crocodylian cranial anatomy and snout shape. The close relationship between Voay and Crocodylus lends additional context for understanding the biogeographic origins of these genera and refines competing hypotheses for the recent extinction of Voay from Madagascar.
- Published
- 2021
- Full Text
- View/download PDF
30. Cannabinoids affect the mouse visual acuity via the cannabinoid receptor type 2.
- Author
-
Cécyre B, Bachand I, Papineau F, Brochu C, Casanova C, and Bouchard JF
- Subjects
- Amacrine Cells drug effects, Animals, Female, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Retina drug effects, Retinal Cone Photoreceptor Cells metabolism, Visual Acuity drug effects, Amacrine Cells physiology, Cannabinoids pharmacology, Receptor, Cannabinoid, CB1 physiology, Receptor, Cannabinoid, CB2 physiology, Retina physiology, Visual Acuity physiology
- Abstract
Recently, there have been increasing indications that the endocannabinoid (eCB) system is involved in vision. Multiple research teams studied the cannabinoid receptor type 2 (CB2R) expression and function in the mouse retina. Here, we examined the consequence of CB2R modulation on visual acuity using genetic and pharmacologic tools. We found that Cnr2 knockout mice show an enhanced visual acuity, CB2R activation decreased visual acuity while CB2R blockade with the inverse agonist AM630 increased it. The inhibition of 2-arachidonylglycerol (2-AG) synthesis and degradation also greatly increased and decreased visual acuity, respectively. No differences were seen when the cannabinoid receptor type 1 (CB1R) was deleted, blocked or activated implying that CB2R exclusively mediates cannabinoid modulation of the visual acuity. We also investigated the role of cannabinoids in retinal function using electroretinography (ERG). We found that modulating 2-AG levels affected many ERG components, such as the a-wave and oscillatory potentials (OPs), suggesting an impact on cones and amacrine cells. Taken together, these results reveal that CB2R modulates visual acuity and that eCBs such as 2-AG can modulate both visual acuity and retinal sensitivity. Finally, these findings establish that CB2R is present in visual areas and regulates vision-related functions.
- Published
- 2020
- Full Text
- View/download PDF
31. Does skull morphology constrain bone ornamentation? A morphometric analysis in the Crocodylia.
- Author
-
Clarac F, Souter T, Cubo J, de Buffrénil V, Brochu C, and Cornette R
- Subjects
- Animals, Phylogeny, Alligators and Crocodiles anatomy & histology, Skull anatomy & histology
- Abstract
Previous quantitative assessments of the crocodylians' dermal bone ornamentation (this ornamentation consists of pits and ridges) has shown that bone sculpture results in a gain in area that differs between anatomical regions: it tends to be higher on the skull table than on the snout. Therefore, a comparative phylogenetic analysis within 17 adult crocodylian specimens representative of the morphological diversity of the 24 extant species has been performed, in order to test if the gain in area due to ornamentation depends on the skull morphology, i.e. shape and size. Quantitative assessment of skull size and shape through geometric morphometrics, and of skull ornamentation through surface analyses, produced a dataset that was analyzed using phylogenetic least-squares regression. The analyses reveal that none of the variables that quantify ornamentation, be they on the snout or the skull table, is correlated with the size of the specimens. Conversely, there is more disparity in the relationships between skull conformations (longirostrine vs. brevirostrine) and ornamentation. Indeed, both parameters GApit (i.e. pit depth and shape) and OArelat (i.e. relative area of the pit set) are negatively correlated with snout elongation, whereas none of the values quantifying ornamentation on the skull table is correlated with skull conformation. It can be concluded that bone sculpture on the snout is influenced by different developmental constrains than on the skull table and is sensible to differences in the local growth 'context' (allometric processes) prevailing in distinct skull parts. Whatever the functional role of bone ornamentation on the skull, if any, it seems to be restricted to some anatomical regions at least for the longirostrine forms that tend to lose ornamentation on the snout., (© 2016 Anatomical Society.)
- Published
- 2016
- Full Text
- View/download PDF
32. Discovery of BI 207524, an indole diamide NS5B thumb pocket 1 inhibitor with improved potency for the potential treatment of chronic hepatitis C virus infection.
- Author
-
Beaulieu PL, Anderson PC, Bethell R, Bös M, Bousquet Y, Brochu C, Cordingley MG, Fazal G, Garneau M, Gillard JR, Kawai S, Marquis M, McKercher G, Poupart MA, Stammers T, Thavonekham B, Wernic D, Duan J, and Kukolj G
- Subjects
- Acrylates metabolism, Acrylates pharmacokinetics, Animals, Antiviral Agents pharmacology, Cinnamates chemical synthesis, Cinnamates metabolism, Cinnamates pharmacokinetics, Dogs, Enzyme Inhibitors chemical synthesis, Enzyme Inhibitors metabolism, Enzyme Inhibitors pharmacokinetics, Hepatitis C, Chronic, Humans, Indoles metabolism, Indoles pharmacokinetics, Macaca mulatta, RNA-Dependent RNA Polymerase antagonists & inhibitors, Rats, Structure-Activity Relationship, Acrylates chemical synthesis, Antiviral Agents chemical synthesis, Antiviral Agents metabolism, Indoles chemical synthesis, Viral Nonstructural Proteins antagonists & inhibitors
- Abstract
The development of interferon-free regimens for the treatment of chronic HCV infection constitutes a preferred option that is expected in the future to provide patients with improved efficacy, better tolerability, and reduced risk for emergence of drug-resistant virus. We have pursued non-nucleoside NS5B polymerase allosteric inhibitors as combination partners with other direct acting antivirals (DAAs) having a complementary mechanism of action. Herein, we describe the discovery of a potent follow-up compound (BI 207524, 27) to the first thumb pocket 1 NS5B inhibitor to demonstrate antiviral activity in genotype 1 HCV infected patients, BILB 1941 (1). Cell-based replicon potency was significantly improved through electronic modulation of the pKa of the carboxylic acid function of the lead molecule. Subsequent ADME-PK optimization lead to 27, a predicted low clearance compound in man. The preclinical profile of inhibitor 27 is discussed, as well as the identification of a genotoxic metabolite that led to the discontinuation of the development of this compound.
- Published
- 2014
- Full Text
- View/download PDF
33. Molecular dynamics simulations and structure-based rational design lead to allosteric HCV NS5B polymerase thumb pocket 2 inhibitor with picomolar cellular replicon potency.
- Author
-
Hucke O, Coulombe R, Bonneau P, Bertrand-Laperle M, Brochu C, Gillard J, Joly MA, Landry S, Lepage O, Llinàs-Brunet M, Pesant M, Poirier M, Poirier M, McKercher G, Marquis M, Kukolj G, Beaulieu PL, and Stammers TA
- Subjects
- Allosteric Regulation, Antiviral Agents chemistry, Cell Line, Crystallography, X-Ray, Enzyme Inhibitors chemistry, Hepacivirus enzymology, Hepacivirus genetics, Molecular Dynamics Simulation, Structure-Activity Relationship, Antiviral Agents pharmacology, Enzyme Inhibitors pharmacology, Hepacivirus drug effects, Replicon drug effects, Viral Nonstructural Proteins antagonists & inhibitors
- Abstract
The design and preliminary SAR of a new series of 1H-quinazolin-4-one (QAZ) allosteric HCV NS5B thumb pocket 2 (TP-2) inhibitors was recently reported. To support optimization efforts, a molecular dynamics (MD) based modeling workflow was implemented, providing information on QAZ binding interactions with NS5B. This approach predicted a small but critical ligand-binding induced movement of a protein backbone region which increases the pocket size and improves access to the backbone carbonyl groups of Val 494 and Pro 495. This localized backbone shift was consistent with key SAR results and was subsequently confirmed by X-ray crystallography. The MD protocol guided the design of inhibitors, exploiting novel H-bond interactions with the two backbone carbonyl groups, leading to the first thumb pocket 2 NS5B inhibitor with picomolar antiviral potency in genotype (gt) 1a and 1b replicons (EC50 = 120 and 110 pM, respectively) and with EC50 ≤ 80 nM against gt 2-6.
- Published
- 2014
- Full Text
- View/download PDF
34. Conformation-based restrictions and scaffold replacements in the design of hepatitis C virus polymerase inhibitors: discovery of deleobuvir (BI 207127).
- Author
-
LaPlante SR, Bös M, Brochu C, Chabot C, Coulombe R, Gillard JR, Jakalian A, Poirier M, Rancourt J, Stammers T, Thavonekham B, Beaulieu PL, Kukolj G, and Tsantrizos YS
- Subjects
- Antiviral Agents chemistry, Benzimidazoles chemistry, Crystallography, X-Ray, Enzyme Inhibitors chemistry, Hepacivirus enzymology, Indoles chemistry, Magnetic Resonance Spectroscopy, Models, Molecular, Molecular Conformation, Antiviral Agents pharmacology, Benzimidazoles pharmacology, Drug Design, Enzyme Inhibitors pharmacology, Hepacivirus drug effects, Indoles pharmacology, Viral Nonstructural Proteins antagonists & inhibitors
- Abstract
Conformational restrictions of flexible torsion angles were used to guide the identification of new chemotypes of HCV NS5B inhibitors. Sites for rigidification were based on an acquired conformational understanding of compound binding requirements and the roles of substituents in the free and bound states. Chemical bioisosteres of amide bonds were explored to improve cell-based potency. Examples are shown, including the design concept that led to the discovery of the phase III clinical candidate deleobuvir (BI 207127). The structure-based strategies employed have general utility in drug design.
- Published
- 2014
- Full Text
- View/download PDF
35. Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1.
- Author
-
Fader LD, Malenfant E, Parisien M, Carson R, Bilodeau F, Landry S, Pesant M, Brochu C, Morin S, Chabot C, Halmos T, Bousquet Y, Bailey MD, Kawai SH, Coulombe R, LaPlante S, Jakalian A, Bhardwaj PK, Wernic D, Schroeder P, Amad M, Edwards P, Garneau M, Duan J, Cordingley M, Bethell R, Mason SW, Bös M, Bonneau P, Poupart MA, Faucher AM, Simoneau B, Fenwick C, Yoakim C, and Tsantrizos Y
- Abstract
An assay recapitulating the 3' processing activity of HIV-1 integrase (IN) was used to screen the Boehringer Ingelheim compound collection. Hit-to-lead and lead optimization beginning with compound 1 established the importance of the C3 and C4 substituent to antiviral potency against viruses with different aa124/aa125 variants of IN. The importance of the C7 position on the serum shifted potency was established. Introduction of a quinoline substituent at the C4 position provided a balance of potency and metabolic stability. Combination of these findings ultimately led to the discovery of compound 26 (BI 224436), the first NCINI to advance into a phase Ia clinical trial.
- Published
- 2014
- Full Text
- View/download PDF
36. Design, synthesis and biological evaluation of novel aminothiazoles as antiviral compounds acting against human rhinovirus.
- Author
-
Décor A, Grand-Maître C, Hucke O, O'Meara J, Kuhn C, Constantineau-Forget L, Brochu C, Malenfant E, Bertrand-Laperle M, Bordeleau J, Ghiro E, Pesant M, Fazal G, Gorys V, Little M, Boucher C, Bordeleau S, Turcotte P, Guo T, Garneau M, Spickler C, and Gauthier A
- Subjects
- Antiviral Agents chemical synthesis, Antiviral Agents chemistry, Dose-Response Relationship, Drug, Humans, Microbial Sensitivity Tests, Molecular Structure, Structure-Activity Relationship, Thiazoles chemical synthesis, Thiazoles chemistry, Antiviral Agents pharmacology, Drug Design, Rhinovirus drug effects, Thiazoles pharmacology
- Abstract
We describe here the design, synthesis and biological evaluation of antiviral compounds acting against human rhinovirus (HRV). A series of aminothiazoles demonstrated pan-activity against the HRV genotypes screened and productive structure-activity relationships. A comprehensive investigational library was designed and performed allowing the identification of potent compounds with lower molecular weight and improved ADME profile. 31d-1, 31d-2, 31f showed good exposures in CD-1 mice. The mechanism of action was discovered to be a host target: the lipid kinase phosphatidylinositol 4-kinase III beta (PI4KIIIß). The identification of the pan-HRV active compound 31f combined with a structurally distinct literature compound T-00127-HEV1 allowed the assessment of target related tolerability of inhibiting this kinase for a short period of time in order to prevent HRV replication., (Copyright © 2013 Elsevier Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
37. A novel cis-acting element from the 3'UTR of DNA damage-binding protein 2 mRNA links transcriptional and post-transcriptional regulation of gene expression.
- Author
-
Melanson BD, Cabrita MA, Bose R, Hamill JD, Pan E, Brochu C, Marcellus KA, Zhao TT, Holcik M, and McKay BC
- Subjects
- Cell Line, DNA-Binding Proteins analysis, Green Fluorescent Proteins analysis, Green Fluorescent Proteins genetics, Humans, Inverted Repeat Sequences, Recombinant Fusion Proteins analysis, Regulatory Sequences, Ribonucleic Acid, 3' Untranslated Regions, DNA-Binding Proteins genetics, RNA Processing, Post-Transcriptional, RNA Stability, RNA, Messenger metabolism, Transcription, Genetic
- Abstract
The DNA damage-binding protein 2 (DDB2) is an adapter protein that can direct a modular Cul4-DDB1-RING E3 Ligase complex to sites of ultraviolet light-induced DNA damage to ubiquitinate substrates during nucleotide excision repair. The DDB2 transcript is ultraviolet-inducible; therefore, its regulation is likely important for its function. Curiously, the DDB2 mRNA is reportedly short-lived, but the transcript does not contain any previously characterized cis-acting determinants of mRNA stability in its 3' untranslated region (3'UTR). Here, we used a tetracycline regulated d2EGFP reporter construct containing specific 3'UTR sequences from DDB2 to identify novel cis-acting elements that regulate mRNA stability. Synthetic 3'UTRs corresponding to sequences as short as 25 nucleotides from the central region of the 3'UTR of DDB2 were sufficient to accelerate decay of the heterologous reporter mRNA. Conversely, these same 3'UTRs led to more rapid induction of the reporter mRNA, export of the message to the cytoplasm and the subsequent accumulation of the encoded reporter protein, indicating that this newly identified cis-acting element affects transcriptional and post-transciptional processes. These results provide clear evidence that nuclear and cytoplasmic processing of the DDB2 mRNA is inextricably linked.
- Published
- 2013
- Full Text
- View/download PDF
38. NF-κB-dependent role for cold-inducible RNA binding protein in regulating interleukin 1β.
- Author
-
Brochu C, Cabrita MA, Melanson BD, Hamill JD, Lau R, Pratt MA, and McKay BC
- Subjects
- Cell Adhesion Molecules genetics, Cell Adhesion Molecules immunology, Cold Temperature, Fibroblasts, Gene Expression Regulation drug effects, Gene Expression Regulation radiation effects, Humans, I-kappa B Proteins genetics, I-kappa B Proteins immunology, Interleukin-1beta immunology, Interleukin-8 genetics, Interleukin-8 immunology, Lipopolysaccharides pharmacology, NF-KappaB Inhibitor alpha, NF-kappa B immunology, Oligonucleotide Array Sequence Analysis, Phosphorylation drug effects, Phosphorylation radiation effects, Primary Cell Culture, Promoter Regions, Genetic, RNA, Messenger genetics, RNA, Small Interfering genetics, RNA-Binding Proteins antagonists & inhibitors, RNA-Binding Proteins immunology, Signal Transduction drug effects, Signal Transduction radiation effects, Ultraviolet Rays, Interleukin-1beta genetics, NF-kappa B genetics, RNA, Messenger biosynthesis, RNA-Binding Proteins genetics
- Abstract
The cold inducible RNA binding protein (CIRBP) responds to a wide array of cellular stresses, including short wavelength ultraviolet light (UVC), at the transcriptional and post-translational level. CIRBP can bind the 3'untranslated region of specific transcripts to stabilize them and facilitate their transport to ribosomes for translation. Here we used RNA interference and oligonucleotide microarrays to identify potential downstream targets of CIRBP induced in response to UVC. Twenty eight transcripts were statistically increased in response to UVC and these exhibited a typical UVC response. Only 5 of the 28 UVC-induced transcripts exhibited a CIRBP-dependent pattern of expression. Surprisingly, 3 of the 5 transcripts (IL1B, IL8 and TNFAIP6) encoded proteins important in inflammation with IL-1β apparently contributing to IL8 and TNFAIP6 expression in an autocrine fashion. UVC-induced IL1B expression could be inhibited by pharmacological inhibition of NFκB suggesting that CIRBP was affecting NF-κB signaling as opposed to IL1B mRNA stability directly. Bacterial lipopolysaccharide (LPS) was used as an activator of NF-κB to further study the potential link between CIRBP and NFκB. Transfection of siRNAs against CIRBP reduced the extent of the LPS-induced phosphorylation of IκBα, NF-κB DNA binding activity and IL-1β expression. The present work firmly establishes a novel link between CIRBP and NF-κB signaling in response to agents with diverse modes of action. These results have potential implications for disease states associated with inflammation.
- Published
- 2013
- Full Text
- View/download PDF
39. Importance of ligand bioactive conformation in the discovery of potent indole-diamide inhibitors of the hepatitis C virus NS5B.
- Author
-
LaPlante SR, Gillard JR, Jakalian A, Aubry N, Coulombe R, Brochu C, Tsantrizos YS, Poirier M, Kukolj G, and Beaulieu PL
- Subjects
- Allosteric Regulation, Diamide metabolism, Enzyme Inhibitors chemistry, Enzyme Inhibitors metabolism, Enzyme Inhibitors pharmacology, Inhibitory Concentration 50, Ligands, Models, Molecular, Viral Nonstructural Proteins chemistry, Viral Nonstructural Proteins metabolism, Diamide chemistry, Diamide pharmacology, Drug Discovery, Hepacivirus, Indoles chemistry, Molecular Conformation, Viral Nonstructural Proteins antagonists & inhibitors
- Abstract
Significant advances have led to receptor induced-fit and conformational selection models for describing bimolecular recognition, but a more comprehensive view must evolve to also include ligand shape and conformational changes. Here, we describe an example where a ligand's "structural hinge" influences potency by inducing an "L-shape" bioactive conformation, and due to its solvent exposure in the complex, reasonable conformation-activity-relationships can be qualitatively attributed. From a ligand design perspective, this feature was exploited by successful linker hopping to an alternate "structural hinge" that led to a new and promising chemical series which matched the ligand bioactive conformation and the pocket bioactive space. Using a combination of X-ray crystallography, NMR and modeling with support from binding-site resistance mutant studies and photoaffinity labeling experiments, we were able to derive inhibitor-polymerase complexes for various chemical series.
- Published
- 2010
- Full Text
- View/download PDF
40. N-Acetamideindolecarboxylic acid allosteric 'finger-loop' inhibitors of the hepatitis C virus NS5B polymerase: discovery and initial optimization studies.
- Author
-
Beaulieu PL, Jolicoeur E, Gillard J, Brochu C, Coulombe R, Dansereau N, Duan J, Garneau M, Jakalian A, Kühn P, Lagacé L, LaPlante S, McKercher G, Perrault S, Poirier M, Poupart MA, Stammers T, Thauvette L, Thavonekham B, and Kukolj G
- Subjects
- Acetamides pharmacology, Allosteric Regulation drug effects, Allosteric Regulation physiology, Antiviral Agents pharmacology, Caco-2 Cells, Carboxylic Acids pharmacology, Cell Line, DNA-Directed RNA Polymerases antagonists & inhibitors, DNA-Directed RNA Polymerases metabolism, Hepacivirus drug effects, Humans, Microsomes, Liver enzymology, RNA-Dependent RNA Polymerase metabolism, Viral Nonstructural Proteins metabolism, Acetamides chemistry, Antiviral Agents chemical synthesis, Carboxylic Acids chemistry, Drug Discovery methods, Hepacivirus enzymology, RNA-Dependent RNA Polymerase antagonists & inhibitors, Viral Nonstructural Proteins antagonists & inhibitors
- Abstract
SAR studies at the N(1)-position of allosteric indole-based HCV NS5B inhibitors has led to the discovery of acetamide derivatives with good cellular potency in subgenomic replicons (EC(50) <200 nM). This class of inhibitors displayed improved physicochemical properties and favorable ADME-PK profiles over previously described analogs in this class., (Copyright (c) 2010 Elsevier Ltd. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
41. Preliminary evidence of safety following administration of L-DOPA and buspirone in an incomplete monoplegic patient.
- Author
-
Guertin PA and Brochu C
- Subjects
- Adult, Anti-Anxiety Agents adverse effects, Anti-Anxiety Agents therapeutic use, Antiparkinson Agents adverse effects, Antiparkinson Agents therapeutic use, Buspirone therapeutic use, Central Nervous System Venous Angioma surgery, Cerebral Palsy etiology, Cerebral Palsy physiopathology, Dose-Response Relationship, Drug, Drug Therapy, Combination, Humans, Leg blood supply, Levodopa therapeutic use, Male, Movement drug effects, Movement physiology, Postoperative Complications etiology, Postoperative Complications pathology, Postoperative Complications physiopathology, Regional Blood Flow drug effects, Treatment Outcome, Buspirone adverse effects, Cerebral Palsy drug therapy, Levodopa adverse effects, Postoperative Complications drug therapy
- Abstract
Study Design: Case report., Objectives: To report a case where a monoplegic patient received L-DOPA and/or buspirone. These compounds, normally used in the treatment of Parkinson's disease and anxiety respectively, were recently shown to induce spinal locomotor network activity and reflex stepping-like movements in animal models of spinal cord injury (SCI). However, the safety of these drugs as potential treatments for Central Pattern Generator (CPG) activation in paralyzed individuals remain unclear., Setting: St-Jean-Chrysostome, Quebec, Canada., Method: The acute effects induced by these compounds were qualitatively assessed by the patient, a 38-year-old man who underwent surgery 17 years ago to remove an intracavernous angioma located at the mid-thoracic level (T5-T6) of the spinal cord., Results: Self-administration every 2 days of L-DOPA (200, 400 and 600 mg, p.o.) and buspirone (5, 10 and 15 mg, p.o.) either separately or combined led to no atypical side effects (that is, occasional sleepiness, nervousness, insomnia or mild headaches). No movement was induced ipsilaterally although some sensations referred to by the patient as an increased blood flow in the lower back and upper leg regions were reported shortly after administration of the combined treatment., Conclusion: The results show no significant side effects following acute administration of L-DOPA and/or buspirone. This constitutes the first report providing preliminary evidence of safety following administration of these drugs in incompletely paralyzed individuals. The sensations of increased blood flow ipsilaterally with the combined treatment may also suggest that the dose regimen was not optimal or sub-threshold for inducing detectable CPG-mediated leg movements.
- Published
- 2009
- Full Text
- View/download PDF
42. Improved replicon cellular activity of non-nucleoside allosteric inhibitors of HCV NS5B polymerase: from benzimidazole to indole scaffolds.
- Author
-
Beaulieu PL, Gillard J, Bykowski D, Brochu C, Dansereau N, Duceppe JS, Haché B, Jakalian A, Lagacé L, LaPlante S, McKercher G, Moreau E, Perreault S, Stammers T, Thauvette L, Warrington J, and Kukolj G
- Subjects
- Allosteric Regulation, Cell Line, Humans, Inhibitory Concentration 50, RNA-Dependent RNA Polymerase antagonists & inhibitors, Structure-Activity Relationship, Benzimidazoles pharmacology, Hepacivirus drug effects, Indoles pharmacology, Replicon drug effects, Viral Nonstructural Proteins antagonists & inhibitors
- Abstract
Benzimidazole-based allosteric inhibitors of the hepatitis C virus (HCV) NS5B polymerase were diversified to a variety of topologically related scaffolds. Replacement of the polar benzimidazole core by lipophilic indoles led to inhibitors with improved potency in the cell-based subgenomic HCV replicon system. Transposing the indole scaffold into a previously described series of benzimidazole-tryptophan amides generated the most potent inhibitors of HCV RNA replication in cell culture reported to date in this series (EC(50) approximately 50 nM).
- Published
- 2006
- Full Text
- View/download PDF
43. Potent inhibitors of the hepatitis C virus NS3 protease: design and synthesis of macrocyclic substrate-based beta-strand mimics.
- Author
-
Goudreau N, Brochu C, Cameron DR, Duceppe JS, Faucher AM, Ferland JM, Grand-Maître C, Poirier M, Simoneau B, and Tsantrizos YS
- Subjects
- Binding Sites, Drug Design, Magnetic Resonance Spectroscopy, Mass Spectrometry, Models, Molecular, Molecular Mimicry, Protease Inhibitors chemistry, Protease Inhibitors chemical synthesis, Protease Inhibitors pharmacology, Viral Nonstructural Proteins antagonists & inhibitors
- Abstract
The virally encoded NS3 protease is essential to the life cycle of the hepatitis C virus (HCV), an important human pathogen causing chronic hepatitis, cirrhosis of the liver, and hepatocellular carcinoma. The design and synthesis of 15-membered ring beta-strand mimics which are capable of inhibiting the interactions between the HCV NS3 protease enzyme and its polyprotein substrate will be described. The binding interactions between a macrocyclic ligand and the enzyme were explored by NMR and molecular dynamics, and a model of the ligand/enzyme complex was developed.
- Published
- 2004
- Full Text
- View/download PDF
44. The heat shock protein HSP70 and heat shock cognate protein HSC70 contribute to antimony tolerance in the protozoan parasite leishmania.
- Author
-
Brochu C, Haimeur A, and Ouellette M
- Subjects
- Animals, Antimony therapeutic use, Antimony Potassium Tartrate pharmacology, Cosmids drug effects, Cosmids genetics, Dose-Response Relationship, Drug, Gene Expression drug effects, HSC70 Heat-Shock Proteins, HSP70 Heat-Shock Proteins genetics, Leishmania drug effects, Stress, Physiological chemically induced, Stress, Physiological genetics, Stress, Physiological metabolism, Transfection, Antimony pharmacology, Drug Resistance physiology, HSP70 Heat-Shock Proteins metabolism, Leishmania metabolism, Leishmaniasis drug therapy
- Abstract
Antimony-containing drugs are still the drugs of choice in the treatment of infections caused by the parasite Leishmania. Resistance to antimony is now common in some parts of the world, and several mechanisms of resistance have been described. By transfecting cosmid banks and selecting with potassium antimonyl tartrate (SbIII), we have isolated a cosmid associated with resistance. This cosmid contains 2 copies of the heat shock protein 70 (HSP70) and 1 copy of the heat shock cognate protein 70 (HSC70). Several data linked HSP70 to antimony response and resistance. First, several Leishmania species, both as promastigotes and amastigotes, increased the expression of their HSP70 proteins when grown in the presence of 1 or 2 times the Effect Concentration 50% of SbIII. In several mutants selected for resistance to either SbIII or to the related metal arsenite, the HSP70 proteins were found to be overexpressed. This increase was also observed in revertant cells grown for several passages in the absence of SbIII, suggesting that this increased production of HSP70 is stable. Transfection of HSP70 or HSC70 in Leishmania cells does not confer resistance directly, though these transfectants were better able to tolerate a shock with SbIII. Our results are consistent with HSP70 and HSC70 being a first line of defense against SbIII until more specific and efficient resistance mechanisms take over.
- Published
- 2004
- Full Text
- View/download PDF
45. Synthesis of BILN 2061, an HCV NS3 protease inhibitor with proven antiviral effect in humans.
- Author
-
Faucher AM, Bailey MD, Beaulieu PL, Brochu C, Duceppe JS, Ferland JM, Ghiro E, Gorys V, Halmos T, Kawai SH, Poirier M, Simoneau B, Tsantrizos YS, and Llinàs-Brunet M
- Subjects
- Antiviral Agents chemistry, Carbamates chemistry, Hepacivirus drug effects, Hepacivirus enzymology, Humans, Macrocyclic Compounds chemistry, Molecular Structure, Protease Inhibitors chemistry, Quinolines chemistry, Thiazoles chemistry, Viral Nonstructural Proteins metabolism, Antiviral Agents chemical synthesis, Antiviral Agents pharmacology, Carbamates chemical synthesis, Carbamates pharmacology, Macrocyclic Compounds chemical synthesis, Macrocyclic Compounds pharmacology, Protease Inhibitors chemical synthesis, Protease Inhibitors pharmacology, Quinolines chemical synthesis, Quinolines pharmacology, Thiazoles chemical synthesis, Thiazoles pharmacology, Viral Nonstructural Proteins antagonists & inhibitors
- Abstract
The synthesis of BILN 2061, an NS3 protease inhibitor with proven antiviral effect in humans, was accomplished in a convergent manner from four building blocks. The procedure described here was suitable for the preparation of multigram quantities of BILN 2061 for preclinical pharmacological evaluation., (Copyright 2004 American Chemical Society)
- Published
- 2004
- Full Text
- View/download PDF
46. Structure-activity study on a novel series of macrocyclic inhibitors of the hepatitis C virus NS3 protease leading to the discovery of BILN 2061.
- Author
-
Llinàs-Brunet M, Bailey MD, Bolger G, Brochu C, Faucher AM, Ferland JM, Garneau M, Ghiro E, Gorys V, Grand-Maître C, Halmos T, Lapeyre-Paquette N, Liard F, Poirier M, Rhéaume M, Tsantrizos YS, and Lamarre D
- Subjects
- Administration, Oral, Animals, Antiviral Agents chemistry, Antiviral Agents pharmacology, Biological Availability, Carbamates chemistry, Carbamates pharmacology, Heterocyclic Compounds chemistry, Heterocyclic Compounds pharmacology, Injections, Intravenous, Proline chemistry, Protease Inhibitors chemistry, Protease Inhibitors pharmacology, Rats, Structure-Activity Relationship, Antiviral Agents chemical synthesis, Carbamates chemical synthesis, Hepacivirus enzymology, Heterocyclic Compounds chemical synthesis, Protease Inhibitors chemical synthesis, Viral Nonstructural Proteins antagonists & inhibitors
- Abstract
From the discovery of competitive hexapeptide inhibitors, potent and selective HCV NS3 protease macrocyclic inhibitors have been identified. Structure-activity relationship studies were performed focusing on optimizing the N-terminal carbamate and the aromatic substituent on the (4R)-hydroxyproline moiety. Inhibitors meeting the potency criteria in the cell-based assay and with improved oral bioavailability in rats were identified. BILN 2061 was selected as the best compound, the first NS3 protease inhibitor reported with antiviral activity in man.
- Published
- 2004
- Full Text
- View/download PDF
47. Discovery of small-molecule inhibitors of the ATPase activity of human papillomavirus E1 helicase.
- Author
-
Faucher AM, White PW, Brochu C, Grand-Maître C, Rancourt J, and Fazal G
- Subjects
- Acetates chemistry, Adenosine Triphosphatases chemistry, Antiviral Agents chemical synthesis, Antiviral Agents chemistry, Biphenyl Compounds chemistry, Humans, Oncogene Proteins, Viral chemistry, Structure-Activity Relationship, Sulfones chemistry, Acetates chemical synthesis, Adenosine Triphosphatases antagonists & inhibitors, Biphenyl Compounds chemical synthesis, Oncogene Proteins, Viral antagonists & inhibitors, Papillomaviridae enzymology, Sulfones chemical synthesis
- Abstract
The Boehringer Ingelheim compound collection was screened for inhibitors of the ATPase activity of human papillomavirus E1 helicase to develop antiviral agents that inhibit human papillomavirus (HPV) DNA replication. This screen led to the discovery of (biphenyl-4-sulfonyl)acetic acid 1, which inhibits the ATPase activity of HPV type 6 E1 helicase with a low micromolar IC(50) value. A hit-to-lead exercise rapidly converted 1 into a low nanomolar lead series.
- Published
- 2004
- Full Text
- View/download PDF
48. Modulation of gene expression in Leishmania drug resistant mutants as determined by targeted DNA microarrays.
- Author
-
Guimond C, Trudel N, Brochu C, Marquis N, El Fadili A, Peytavi R, Briand G, Richard D, Messier N, Papadopoulou B, Corbeil J, Bergeron MG, Légaré D, and Ouellette M
- Subjects
- Animals, Antimony pharmacology, Arsenites pharmacology, Blotting, Northern, Drug Resistance, Multiple genetics, Folic Acid Antagonists pharmacology, Gene Expression Regulation drug effects, Genes, Protozoan genetics, Leishmania drug effects, Leishmania major drug effects, Leishmania major genetics, Methotrexate pharmacology, Mutation, RNA, Protozoan genetics, RNA, Protozoan metabolism, Species Specificity, Gene Expression Profiling, Leishmania genetics, Oligonucleotide Array Sequence Analysis methods
- Abstract
In the protozoan parasite Leishmania, drug resistance can be a complex phenomenon. Several metabolic pathways and membrane transporters are implicated in the resistance phenotype. To monitor the expression of these genes, we generated custom DNA microarrays with PCR fragments corresponding to 44 genes involved with drug resistance. Transcript profiling of arsenite and antimony resistant mutants with these arrays pinpointed a number of genes overexpressed in mutants, including the ABC transporter PGPA, the glutathione biosynthesis genes gamma-glutamylcysteine synthetase (GSH1) and the glutathione synthetase (GSH2). Competitive hybridisations with total RNA derived from sensitive and methotrexate resistant cells revealed the overexpression of genes coding for dihydrofolate reductase (DHFR-TS), pteridine reductase (PTR1) and S-adenosylmethionine synthase (MAT2) and a down regulation of one gene of the folate transporter (FT) family. By labelling the DNA of sensitive and resistant parasites we could also detect several gene amplification events using DNA microarrays including the amplification of the S-adenosyl homocysteine hydrolase gene (SAHH). Alteration in gene expression detected by microarrays was validated by northern blot analysis, while Southern blots indicated that most genes overexpressed were also amplified, although other mechanisms were also present. The microarrays were useful in the study of resistant parasites to pinpoint several genes linked to drug resistance.
- Published
- 2003
- Full Text
- View/download PDF
49. Antimony uptake systems in the protozoan parasite Leishmania and accumulation differences in antimony-resistant parasites.
- Author
-
Brochu C, Wang J, Roy G, Messier N, Wang XY, Saravia NG, and Ouellette M
- Subjects
- 2,4-Dinitrophenol pharmacology, Animals, Antimony chemistry, Antimony metabolism, Antimony pharmacology, Antiprotozoal Agents pharmacology, Arsenites metabolism, Cell Line, Dose-Response Relationship, Drug, Drug Resistance, Microbial, Energy Metabolism drug effects, Energy Metabolism physiology, Leishmania drug effects, Leishmania growth & development, Life Cycle Stages, Mass Spectrometry methods, Parasitic Sensitivity Tests, Uncoupling Agents pharmacology, Valinomycin pharmacology, Antimony pharmacokinetics, Leishmania metabolism
- Abstract
The first line drug against leishmaniasis consists of pentavalent antimony [Sb(V)], but there is general belief that the active form of the metal is the trivalent form [Sb(III)]. In this study, we have quantified the accumulation of Sb(V) and Sb(III) in Leishmania by using inductively coupled plasma mass spectrometry. The accumulation was studied in three Leishmania species at various life stages, sensitive or resistant to antimony. Both Sb(III) and Sb(V) are accumulated in promastigote and amastigote parasites, but through competition experiments with arsenite, we found that the routes of entry of Sb(V) and Sb(III) are likely to differ in Leishmania. The level of accumulation of either Sb(III) or Sb(V), however, was not correlated with the susceptibility of wild-type Leishmania cells to antimony. This suggests that other factors may also be implicated in the mode of action of the drugs. In contrast to metal susceptibility, resistance to Sb(III) correlated well with decreased antimony accumulation. This phenotype was energy dependent and highlights the importance of transport systems in drug resistance of this protozoan parasite.
- Published
- 2003
- Full Text
- View/download PDF
50. Thiol-induced reduction of antimony(V) into antimony(III): a comparative study with trypanothione, cysteinyl-glycine, cysteine and glutathione.
- Author
-
Ferreira Cdos S, Martins PS, Demicheli C, Brochu C, Ouellette M, and Frézard F
- Subjects
- Cysteine chemistry, Dipeptides chemistry, Glutathione chemistry, Hydrogen-Ion Concentration, Kinetics, Meglumine chemistry, Organometallic Compounds chemistry, Oxidation-Reduction, Spermidine chemistry, Time Factors, Antimony chemistry, Glutathione analogs & derivatives, Spermidine analogs & derivatives, Sulfhydryl Compounds chemistry
- Abstract
Gluthathione (GSH) has been previously shown to promote the reduction of pentavalent antimony (Sb(V)) into the more toxic trivalent antimony (Sb(II)) in the antimonial drug, meglumine antimonate. However, this reaction occurred at acidic pH (pH 5) but not at the pH of the cytosol (pH 7.2) in which GSH is encountered. The aim of the present study was to further characterize the reaction between thiols and antimonial drugs, addressing the following aspects: (i) the reducing activity of cysteine (Cys) and cysteinyl-glycine (Cys-Gly), expected to be the predominant thiols in the acidic compartments of mammalian cells; (ii) the reducing activity of trypanothione (T(SH)2), the main intracellular thiol in Leishmania parasites; (iii) the influence of the state of complexation of Sb(V) on the rate of Sb(V) reduction. We report here that Cys, Cys-Gly and T(SH)2 did promote the reduction of Sb(V) into Sb(III) at 37 degrees C. Strikingly, the initial rates of reduction of Sb(V) were much greater in the presence of Cys-Gly, Cys and T(SH)2 than in the presence of GSH. These reactions occurred at both pH 5 and pH 7 but were favored at acidic pH. Moreover, our data shows that Sb(V) is reduced more slowly in the form of meglumine antimonate than in its non-complexed form, indicating that the complexation of Sb(V) tends to slow down the rate of its reduction. In conclusion, our data supports the hypothesis that Sb(V) is reduced in vivo by T(SH)2 within Leishmania parasites and by Cys or Cys-Gly within the acidic compartments of mammalian cells.
- Published
- 2003
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.